Skip to main content

Table 2 Characteristics of sAMC patients and healthy controls

From: Abnormal T2 mapping cardiovascular magnetic resonance correlates with adverse clinical outcome in patients with suspected acute myocarditis

 

controls

sAMC

p-value

n = 60

n = 46

Female (n)

17 (28%)

13 (28%)

0.993

Age (years)

43 ± 12

41 ± 16

0.783

   20–34 (n)

23 (38%)

17 (37%)

0.886

   35–49 (n)

23 (38%)

16 (35%)

0.710

    > 50 (n)

14 (23%)

13 (28%)

0.568

BMI (kg/m2)

24 ± 3

25 ± 4

0.819

Creatinine (mg/dl)

n.a.

1.2 ± 1.9

n.a.

CMR Parameters

 LVEF %

62 ± 8

42 ± 15

<0.001

 LVEDVi (ml/m2)

75 ± 18

80 ± 19

0.084

 LVEDDi (ml/m2)

28±5

32±5

0.046

 Presence of LGE (n)

0

37 (80%)

<0.001

 T2 Ratio > 1.9 (n)

7 (12%)

20 (43%)

<0.001

 Global T2 Time (ms)

60.0 ± 4.2

68.1 ± 5.8

<0.001

 Fraction with T2 Time >80 ms (%)

4.1 ± 3.0

17.7 ± 11.5

<0.001

  1. Abbreviations: sAMC suspected acute myocarditis, BMI Body Mass Index, CMR Cardiovascular Magnetic Resonance, LVEF Left ventricular ejection fraction, LVEDVi Left Ventricular End Diastolic Volume index, LVEDDi Left Ventricular End Systolic Diameter index
  2. Values are mean ± standard deviation or percentage